![]() |
市場調查報告書
商品編碼
1822479
2032 年農業生物技術市場預測:按產品類型、性狀類型、作物類型、技術、分銷管道、最終用戶和地區進行的全球分析Agricultural Biotechnology Market Forecasts to 2032 - Global Analysis By Product Type, Trait Type, Crop Type, Technology, Distribution Channel, End User and By Geography |
根據 Stratistics MRC 的數據,全球農業生物技術市場預計到 2025 年將達到 1,373 億美元,到 2032 年將達到 2,478 億美元,預測期內的複合年成長率為 8.8%。
農業生物技術涉及應用包括基因工程和分子生物學在內的科學技術來改良作物、牲畜和耕作方法。這使得開發具有抗蟲、耐旱和產量等特性的基因改造生物 (GMO) 成為可能。該技術透過減少化學投入、提高糧食安全和促進環境保護來支持永續農業。農業生物技術在應對糧食生產、氣候變遷和資源效率等全球挑戰方面發揮關鍵作用。
根據《印度農業科學雜誌》報道,基改作物在印度的引進對農業生產力產生了重大影響。例如,Bt棉花是印度唯一核准商業性批准的基因改造作物,到2022年,其種植面積已超過1,140萬公頃,佔全國棉花總種植面積的90%以上。該雜誌發表的一項研究報告稱,Bt棉花使產量提高了24%,農藥使用量減少了50%,有助於提高農場收入並改善環境。
全球人口成長與糧食安全問題
農業生物技術已成為關鍵解決方案,它能夠開發出抗病蟲害和環境脅迫的基因改造作物。這些創新對於提高糧食供應和營養品質至關重要,尤其是在面臨氣候變遷的地區。 CRISPR 和RNA干擾等技術正被用於改造具有優良性狀的作物,幫助解決營養不良和糧食不安全問題。為了確保長期糧食安全和永續的農業實踐,各國政府和國際組織正在加強對生物技術研究的支持。
監管障礙和冗長的核准流程
基因改造作物(GMO)和生物工程產品的核准流程通常涉及廣泛的安全評估、環境影響評估和公眾諮詢。雖然這些程式對於保護消費者至關重要,但對於開發者來說卻耗時費力。各國法律規範的差異進一步加劇了全球市場准入的複雜性,並限制了創新的步伐。此外,公眾的質疑和圍繞作物的倫理爭議加劇了政策惰性,阻礙了其更廣泛的應用。
農業生物技術與數位技術的結合
遙感探測和基因組數據分析等人工智慧生物資訊學工具正在提高性狀選擇的準確性並加快育種週期。這種整合使農民能夠監測作物健康狀況、預測產量並更有效地利用投入。數位平台也促進了即時決策並提高了供應鏈透明度。隨著智慧農業的普及,生物技術公司正在投資數位基礎設施,以提供客製化解決方案,從而提高生產力和永續性。
對小農戶的社會經濟影響
生物技術種子、許可費和專有技術的高成本可能會限制資源受限的農民取得這些技術。此外,依賴取得專利的性狀可能會削弱種子主權,增加財務脆弱性。向生物技術密集型農業的轉變也可能擾亂傳統的耕作方式,導致農村社區的社會經濟地位下降。解決這些問題需要全面的政策、能力建設措施以及公平獲取生物技術創新的機會。
新冠疫情對農業生物技術市場產生了雙重影響,既擾亂了供應鏈,也加速了創新。停工和勞動力短缺影響了田間試驗、種子生產和分銷網路,導致產品上市延遲。然而,這場危機也凸顯了建立韌性糧食作物的必要性,並刺激了對生物技術解決方案的投資增加。各國政府已將氣候適應性和抗病作物的研究列為優先事項,以減輕未來的干擾。
農作物保護產品市場預計將成為預測期內最大的市場
農作物保護產品領域預計將在預測期內佔據最大的市場佔有率,因為它在保護產量免受病蟲害侵害方面發揮著至關重要的作用。基於生物技術的殺蟲劑、除草劑和殺菌劑因其針對性強且環境安全,越來越受到化學替代品的青睞。微生物生物農藥和基於RNAi的害蟲防治創新技術正日益受到歡迎,因為它們為病蟲害綜合治理提供了永續的解決方案。
預測期內,抗蟲細分市場預計將以最高複合年成長率成長
預計抗蟲作物領域將在預測期內實現最高成長率,這主要得益於減少作物損失和最大程度減少農藥使用的需求。基因工程技術正被用於培育表達殺蟲蛋白的作物,從而提供對主要害蟲的內在保護。這些特性不僅提高了產量穩定性,也降低了農民的投入成本。 CRISPR 和基因堆疊技術的發展使得多重抗性品種的開發成為可能,擴大了抗蟲生物基作物在不同地區的覆蓋範圍。
預計北美將在預測期內佔據最大的市場佔有率,這得益於其強大的科研基礎設施、良好的法規環境以及基因改造作物的廣泛應用。該地區擁有多家大型生物技術公司和學術機構,正在推動基因工程和合成生物學領域的創新。政府對生物技術研發和精密農業計畫的大力支持,進一步推動了市場成長。
受糧食需求成長、氣候挑戰和農業投資擴張的推動,亞太地區預計將在預測期內呈現最高的複合年成長率。中國、印度和印尼等國家正積極擁抱生物技術創新,以提高作物的抗逆性並減少對進口的依賴。政府推動的基因改造作物試驗、數位農業和生物技術教育計畫正在加速該地區的生物技術應用。亞太地區多樣化的農業氣候區也為客製化生物技術應用提供了機會,使其成為未來農業生物技術發展的熱點。
According to Stratistics MRC, the Global Agricultural Biotechnology Market is accounted for $137.3 billion in 2025 and is expected to reach $247.8 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Agricultural biotechnology involves the application of scientific techniques, including genetic engineering and molecular biology, to improve crops, livestock, and farming practices. It enables the development of genetically modified organisms (GMOs) with enhanced traits such as pest resistance, drought tolerance, and increased yield. This technology supports sustainable agriculture by reducing chemical inputs, improving food security, and promoting environmental conservation. Agricultural biotechnology plays a vital role in addressing global challenges related to food production, climate change, and resource efficiency.
According to the Indian Journal of Agricultural Sciences, the adoption of genetically modified (GM) crops in India has significantly impacted agricultural productivity. For instance, Bt cotton India's only commercially approved GM crop was cultivated on over 11.4 million hectares by 2022, accounting for over 90% of the country's total cotton area. Studies published in the journal report that Bt cotton has led to a 24% increase in yield and a 50% reduction in pesticide use, contributing to improved farmer income and environmental outcomes.
Growing global population and food security concerns
Agricultural biotechnology is emerging as a pivotal solution, enabling the development of genetically modified crops that offer improved resistance to pests, diseases, and environmental stressors. These innovations are crucial for enhancing food availability and nutritional quality, especially in regions facing climate volatility. Technologies such as CRISPR and RNA interference are being leveraged to engineer crops with superior traits, helping address malnutrition and food scarcity. Governments and international bodies are increasingly supporting biotech research to ensure long-term food security and sustainable farming practices
Regulatory hurdles and lengthy approval processes
Approval processes for genetically modified organisms (GMOs) and bioengineered products often involve extensive safety evaluations, environmental impact assessments, and public consultations. These procedures, while essential for consumer protection, can be time-consuming and costly for developers. Variability in regulatory frameworks across countries further complicates global market entry, limiting the pace of innovation. Moreover, public skepticism and ethical debates surrounding GM crops contribute to policy inertia, hindering broader adoption
Integration of agricultural biotechnology with digital technologies
Tools such as AI-driven bioinformatics remote sensing and genomic data analytics are enhancing the accuracy of trait selection and accelerating breeding cycles. This integration allows farmers to monitor crop health, predict yield outcomes, and apply inputs more efficiently. Digital platforms are also facilitating real-time decision-making and improving supply chain transparency. As smart farming gains traction, biotech firms are investing in digital infrastructure to deliver tailored solutions that boost productivity and sustainability
Socio-economic impacts on small farmers
High costs associated with biotech seeds, licensing fees, and proprietary technologies can limit accessibility for resource-constrained farmers. Additionally, dependence on patented traits may reduce seed sovereignty and increase financial vulnerability. The shift toward biotech-intensive farming could also disrupt traditional agricultural practices, leading to socio-economic displacement in rural communities. Addressing these concerns requires inclusive policies, capacity-building initiatives, and equitable access to biotech innovations
The COVID-19 pandemic had a dual impact on the agricultural biotechnology market, disrupting supply chains while accelerating innovation. Lockdowns and labor shortages affected field trials, seed production, and distribution networks, causing delays in product launches. However, the crisis also underscored the need for resilient food systems, prompting increased investment in biotech solutions. Governments prioritized research on climate-resilient and disease-resistant crops to mitigate future disruptions.
The crop protection products segment is expected to be the largest during the forecast period
The crop protection products segment is expected to account for the largest market share during the forecast period due to their critical role in safeguarding yields against pests and diseases. Biotech-based pesticides, herbicides, and fungicides are increasingly preferred over chemical alternatives for their targeted action and environmental safety. Innovations in microbial biopesticides and RNAi-based pest control are gaining traction, offering sustainable solutions for integrated pest management.
The insect-resistant segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the insect-resistant segment is predicted to witness the highest growth rate driven by the need to reduce crop losses and minimize pesticide usage. Genetic engineering techniques are being employed to develop crops that express insecticidal proteins, offering built-in protection against major pests. These traits not only enhance yield stability but also lower input costs for farmers. Advances in CRISPR and gene stacking are enabling the development of multi-resistant varieties, expanding the scope of insect-resistant biotech crops across diverse geographies.
During the forecast period, the North America region is expected to hold the largest market share owing to its robust research infrastructure, favorable regulatory environment, and widespread adoption of GM crops. The region is home to several biotech giants and academic institutions driving innovation in genetic engineering and synthetic biology. Strong government support for biotech R&D and precision agriculture initiatives further bolsters market growth.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGRfueled by rising food demand, climate challenges, and expanding agricultural investments. Countries like China, India, and Indonesia are embracing biotech innovations to enhance crop resilience and reduce dependency on imports. Government programs promoting GM crop trials, digital farming, and biotech education are accelerating regional adoption. The region's diverse agro-climatic zones also present opportunities for tailored biotech applications, making Asia Pacific a hotspot for future growth in agricultural biotechnology.
Key players in the market
Some of the key players in Agricultural Biotechnology Market include Bayer AG, Corteva Agriscience, Syngenta AG, BASF SE, FMC Corporation, Novozymes A/S, Valent BioSciences LLC, Certis USA LLC, Evogene Ltd., KWS SAAT SE, Indigo Agriculture, Inc., Bioceres Crop Solutions Corp., Ginkgo Bioworks Holdings Inc., UPL (Natural Plant Protection - NPP), RovensaNext, BioFirst and De Sangosse.
In September 2025, BASF partnered with Arkema and AkzoNobel to reduce carbon footprint of Interpon powder coatings by up to 40%. It supplies bio-attributed neopentyl glycol (NPG ZeroPCF), enabling sustainable building materials.
In August 2025, Corteva and Insecticides India launched SPARCLE, a broad-spectrum insecticide targeting brown plant hopper in rice. The product combines Corteva's advanced chemistry with IIL's distribution network to improve crop yield and profitability.
In June 2025, Novonesis acquired DSM-Firmenich's share of the Feed Enzyme Alliance for €1.5 billion. This move strengthens Novonesis' position in animal biosolutions and expands its distribution.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.